Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 13, Issue 1, 1996, Pages 33-37

  Takeyama, Masaharu ^a   Nagai, Sonoko ^b   Mori, Kazuo ^a   Ikawa, Kazuro ^a   Satake, Norio ^b   Izumi, Takateru ^b  

^a OITA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

bronchoalveolar lavage fluid; idiopathic pulmonary fibrosis; pulmonary function; sarcoidosis; smoking; substance P

Indexed keywords

SUBSTANCE P;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ETIOLOGY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IDIOPATHIC DISEASE; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; PRIORITY JOURNAL; SMOKING;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PULMONARY FIBROSIS; SARCOIDOSIS, PULMONARY; SUBSTANCE P;

EID: 0029954917     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Nagai S, Takeuchi M, Izumi T: The role of BALF macrophages on the epithelioid cell granuloma formation in pulmonary sarcoidosis. In: Yoshida T, Torisu M (eds) Basic mechanisms of granulomatous inflammation, Elsevier Science Publishers, Amsterdam 1989: pp 265-281.
2. Panos RJ, King Jr TE: Idiopathic pulmonary fibrosis. In: Lynch JP, DeRemee RA (eds) Immunologically mediated pulmonary diseases, JB Lippincott, Philadelphia 1991: pp 1-39.
3. Barnes PJ: Neuropeptides in human airways: Function and clinical implications. Am Rev Respir Dis 1987; 136: S77-S83.
4. Barnes PJ, Baraniuk JN, Belvisi MG:, Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144:1187-1198.
5. Lundberg JM, Hökfelt T, Martling CR, Saria A, Cuello C: Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984; 235: 251-261.
6. Barnes PJ: Asthma as axon reflex. Lancet 1986; 1: 242-245.
7. Barnes PJ: Neuropeptides and asthma. Am Rev Respir Dis 1991; 143: S28-S32.
8. Chaen T, Watanabe N, Mogi G, Mori K, Takeyama M: Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy. Ann Otol Rhinol Laryngol 1993; 102: 16-21.
9. Takeyama M, Mori K, Morikawa N, et al: Effect of terfenadine on substance P and vasoactive intestinal polypeptide concentrations in nasal secretions from patients with nasal allergy. J Pharm Phamacol 1994; 46: 41-45.
10. Daniele RP, Elias JA, Epstein PE, Rossman MD: Broncho-alveolar lavage: Role in the pathogenesis, diagnosis and management of interstitial lung disease. Ann Intern Med 1984; 102: 93-108.
11. Izumi T, Nagai S, Kitaichi M, Fujimura N: Clinical value of the measurement of BALF cell subsets in interstitial lung disease. Chest 1986; 89: S137-S138.
12. Takeyama M, Mori K, Takayama F, Kondo K, Kitagawa K, Fujii N: Enzyme immunoassay of a substance P-like immunoreactive substance in human plasma and saliva. Chem Pharm Bull 1990; 38: 3494-3496.
13. Nagai S, Takeuchi M, Watanabe K, Aung H, Izumi T: Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects. Chest 1988; 94: 694-700.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ,: Protein measurement with the folin phenol reagent. J. Biol Chem 1951; 193: 265-275.
15. Cuello AC, Priestley JV, Matthews MR: Localization of substance P in neuronal pathways. In: Ciba Found Sympo 91. Substance P in the nervous system, (Pitman, London) 1982: pp55-83.
16. Emura M, Nagai S, Takeuchi M, Kitaichi M, Izumi T: In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 1990; 82: 133-139.
17. Hunninghake GW, Gadek JE, Lawley TJ, Crystal RG: Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis, J Clin Invest 1981; 68: 259-269.
18. Nagai S, Aung U, Tanaka S, et al: Bronchoalveolar lavage cell findings in patients with BOOP and related diseases, Chest 1992; 102: 32-37.
19. Nagai S, Satake N, Shimoji T et al: Bronchoalveolar lavage findings in patients with idiopathic pulmonary fibrosis. In: Takishima T. (eds) Basic and clinical aspects of pulmonary fibrosis, (CRC Press, Tokyo) 1994; pp 325-339.
20. Payan DG, Goetzl EJ: Substance P receptor-dependent responses of leukocytes in pulmonary inflammation. Am Rev Respir Dis 1987; 136:S39-S43.
21. Perretti M, Ahluwalia A, Flower RJ, Manzini S: Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology 1993; 80: 73-77.
22. Shanahan F, Brogan M, Dang J, Nayersina R, Targan S: Neuropeptide stimulation of the respiratory burst by human phagocytic cells. Fed Proc 1986; 45: 635.
23. Lotz M, Vaughan JH, Carson DA: Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218-1221.
24. Iwamoto I, Yamazaki H, Nakagawa N, Kimura A, Tomioka H, Yoshida S; Differential effects of two C-terminal peptides of substance P on human neutrophils. Neuropeptides 1990; 16: 103-107.
25. Iwamoto I, Tomoe S, Tomioka H, Yoshida S: Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. J Immunol 1993; 151: 2116-2123.
26. Tomoe S, Iwamoto I, Tomioka H, Yoshida S: Comparison of substance P-induced and compound 48/80-induced neutrophil infiltrations in mouse skin, Int Arch Allergy Immunol 1992; 97: 237-242.
27. Nilsson J, von Euler AM, Dalsgaard CJ: Stimulation of connective tissue cell growth by substance P and substance K, Nature 1985; 315: 61-63.
28. Payan D G: Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells, Biochem Biophys Res Commun 1985; 130: 104-109.
29. Lilly CM, Kobzik L, Hall AE, Drazen JM: Effects of chronic airway inflammation on the activity and enzymatic inactivation of neuropeptides in guinea pig lungs, J. Clin Invest 1994; 93: 2667-2674.
30. Payan DG, Brewster DR, Goetzl EJ: Specific stimulation of human T lymphocytes by substance P, J. Immunol 1983; 131: 1613-1615.
31. Balbi B, Moller DR, Kirby M, Holroyd KJ, Crystal RG: Increased numbers of T lymphocytes with γ δ -positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis, J. Clin Invest 1990; 85: 1353-1361.
32. Tang SC, Braunsteiner H, Wiedermann CJ: Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somalostatin and vasoactive intestinal peplide in vitro, Immunol Lett 1992; 34: 237-242.
33. Nio DA, Moylan RN, Roche JK: Modulation of T lymphocyte function by neuropeptides, J. Immunol 1993; 150: 5281-5288.
34. Kavelaars A, Jeurissen F, Künzel JFD, van Roijen JH, Rijkers GT, Heijnen CJ: Substance P induces a rise in intracellular calcium concentration in human T lymphocytes in vitro: evidence of a receptor-independent mechanism, J.Neuroimmunol 1993 42: 61-70.